DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Gynecologic Oncology Group. Markman M, Blessing J. et al.
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study.
Gynecol Oncol 2006;
101: 436-440
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.